Expected earnings - INmune Bio Inc.
Source: US Earnings Reports
INmune Bio Inc. (INMB) is expected to report $-0.37 for Q2 2025
INmune Bio Inc.
NASDAQ: INMB
INMB Trading
-3.93% G/L:
$1.59 Last:
342,332 Volume:
$1.66 Open:
INMB Latest News
May 15, 2026 08:00:00 am
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro(TM) PlatformMay 14, 2026 08:00:00 am
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's DiseaseINMB Stock Data
$100,001,939
20,608,626
3.69%
19
N/A
Biotechnology & Life Sciences
Healthcare
US
Boca Raton
